Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Growth and Development Study of Alglucosidase Alfa.
A Long-term Study to Evaluate Growth and Development Outcomes in Patients With Infantile-Onset Pompe Disease Who Are Receiving Alglucosidase Alfa.
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Detroit, MI
Growth and Development Study of Alglucosidase Alfa.
A Long-term Study to Evaluate Growth and Development Outcomes in Patients With Infantile-Onset Pompe Disease Who Are Receiving Alglucosidase Alfa.
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Little Rock, AR
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Orlando, FL
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Wellington, FL
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Wellington, FL
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Canton, GA
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Canton, GA
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Crystal Lake, IL
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Crystal Lake, IL
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
North Platte, NE
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
North Platte, NE
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Reno, NV
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Reno, NV
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Burlington, NC
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Burlington, NC
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Greensboro, NC
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Greensboro, NC
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Morganton, NC
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Morganton, NC
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Tabor City, NC
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Tabor City, NC
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Johnstown, PA
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Johnstown, PA
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Levittown, PA
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Levittown, PA
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Charleston, SC
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Kingsport, TN
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Kingsport, TN
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Dallas, TX
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Ft.Worth, TX
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Ft.Worth, TX
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Georgetown, TX
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Georgetown, TX
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Houston, TX
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Plano, TX
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Plano, TX
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Alexandria, VA
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Alexandria, VA
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Richmond, VA
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
mi
from
Buenos Aires,
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
mi
from
Buenos Aires,
Click here to add this to my saved trials
Evaluation of 18F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass
Scan Re-Scan Pancreatic Beta Cell Imaging Using PET Imaging and 18F-FP-DTBZ
Status: Enrolling
Updated:  10/27/2015
Naomi Berrie Diabetes Center
mi
from
New York, NY
Evaluation of 18F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass
Scan Re-Scan Pancreatic Beta Cell Imaging Using PET Imaging and 18F-FP-DTBZ
Status: Enrolling
Updated: 10/27/2015
Naomi Berrie Diabetes Center
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated:  10/28/2015
Retina Group of Florida
mi
from
Fort Lauderdale, FL
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated: 10/28/2015
Retina Group of Florida
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated:  10/28/2015
Johns Hopkins Unversity
mi
from
Baltimore, MD
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated: 10/28/2015
Johns Hopkins Unversity
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated:  10/28/2015
Valley Retina Institute, P.A.
mi
from
McAllen, TX
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated: 10/28/2015
Valley Retina Institute, P.A.
mi
from
McAllen, TX
Click here to add this to my saved trials
Retinal Blood Flow and Microthrombi in Type 1 Diabetes
Retinal Blood Flow and Microthrombi in Type 1 Diabetes
Status: Enrolling
Updated:  10/28/2015
Schepens Eye Research Institute
mi
from
Boston, MA
Retinal Blood Flow and Microthrombi in Type 1 Diabetes
Retinal Blood Flow and Microthrombi in Type 1 Diabetes
Status: Enrolling
Updated: 10/28/2015
Schepens Eye Research Institute
mi
from
Boston, MA
Click here to add this to my saved trials
OMT of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus
Osteopathic Manipulative Treatment of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  10/29/2015
University of North Texas Health Science Center
mi
from
Fort Worth, TX
OMT of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus
Osteopathic Manipulative Treatment of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 10/29/2015
University of North Texas Health Science Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period
An Observational Study Evaluating Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period
Status: Enrolling
Updated:  10/29/2015
Novo Nordisk Clinical Trial Call Center
mi
from
Princeton, NJ
Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period
An Observational Study Evaluating Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period
Status: Enrolling
Updated: 10/29/2015
Novo Nordisk Clinical Trial Call Center
mi
from
Princeton, NJ
Click here to add this to my saved trials
A Study to Assess the Relative Bioavailability and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy Participants
A Phase 1, Randomized, Open-Label, Single-Dose, 3-Way Crossover Study to Assess the Relative Bioavailability of a TAK-648 Tablet Compared With a TAK-648 Oral Solution, and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy Participants
Status: Enrolling
Updated:  10/29/2015
Clinical Research Facility
mi
from
Austin, TX
A Study to Assess the Relative Bioavailability and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy Participants
A Phase 1, Randomized, Open-Label, Single-Dose, 3-Way Crossover Study to Assess the Relative Bioavailability of a TAK-648 Tablet Compared With a TAK-648 Oral Solution, and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy Participants
Status: Enrolling
Updated: 10/29/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Diabetes Technology Study of Real-Time Glucose Alerts in the Team Management of Diabetes
Non-Significant Risk Investigational Device Study of the Wireless GlucoMON™ Glucose Meter Accessory and Real-time Blood Glucose Alerts as an Enabling Technology for People Who Team Manage Diabetes
Status: Enrolling
Updated:  10/30/2015
Diabetech
mi
from
Dallas, TX
Diabetes Technology Study of Real-Time Glucose Alerts in the Team Management of Diabetes
Non-Significant Risk Investigational Device Study of the Wireless GlucoMON™ Glucose Meter Accessory and Real-time Blood Glucose Alerts as an Enabling Technology for People Who Team Manage Diabetes
Status: Enrolling
Updated: 10/30/2015
Diabetech
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Montgomery, AL
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Montgomery, AL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Phoenix, AZ
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Phoenix, AZ
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Little Rock, AR
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Northridge, CA
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Northridge, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Norwalk, CA
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Norwalk, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Rancho Cucamonga, CA
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
San Ramon, CA
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
San Ramon, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Aurora, CO
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Denver, CO
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Littleton, CO
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Littleton, CO
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Cooper City, FL
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Cooper City, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
North Miami Beach, FL
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Atlanta, GA
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Perry, GA
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Perry, GA
Click here to add this to my saved trials